TFDP2 antibody Polyclonal Antibodies Primary antibodies
- Known as:
- TFDP2 (anti-) Polyclonal Antibodies Primary antibodies
- Catalog number:
- orb100034
- Product Quantity:
- 100
- Category:
- -
- Supplier:
- Biorb
- Gene target:
- TFDP2 antibody Polyclonal Antibodies Primary antibodies
Related genes to: TFDP2 antibody Polyclonal Antibodies Primary antibodies
- Gene:
- TFDP2 NIH gene
- Name:
- transcription factor Dp-2
- Previous symbol:
- -
- Synonyms:
- Dp-2
- Chromosome:
- 3q23
- Locus Type:
- gene with protein product
- Date approved:
- 1995-12-15
- Date modifiied:
- 2016-04-04
Related products to: TFDP2 antibody Polyclonal Antibodies Primary antibodies
Related articles to: TFDP2 antibody Polyclonal Antibodies Primary antibodies
- Diabetic kidney disease (DKD) is a major microvascular complication of diabetes, characterized by abnormal mesangial cell (MC) proliferation, yet the underlying mechanisms remain unclear. - Source: PubMed
Publication date: 2026/02/02
Wang QijiaChong XinyuLiu HandengPeng RuiPeng XuemeiLiao XiaohuiSun YanZhang Zheng - Dysregulation of apoptosis-related genes (ARGs) may contribute to tumorigenesis and impact patient prognosis, but their specific influence on prognosis and immune characteristics in diffuse large B-cell lymphoma (DLBCL) remains unclear. - Source: PubMed
Publication date: 2026/02/03
Xu YuxiuSun XiaoliYang JingMa DongshengWan JiangweiLei TingtingWang Tao - - Source: PubMed
Publication date: 2025/05/17
Zhang ShuweiWang ChanLiu JianxingLiu LiuMiao LinWang HaoweiTian YunqingCheng HaoLi JuanZeng Xiaofeng - Methamphetamine (METH) is a synthetic drug with potent addictive, relapse, and neurotoxic properties. METH abuse contributes to severe damage to the central nervous system, potentially causing cognitive impairments, behavioral changes, and neurodegenerative diseases. METH-induced neuronal damage is closely related to apoptosis and cell cycle abnormalities, while gene expression regulator microRNAs (miRNAs) may play extensive roles in this progress, but the specific mechanisms remain unclear. We found that the novel miRNA 146 (miR_146) was downregulated in METH-induced apoptosis and cell cycle arrest in tree shrew primary neurons, while the expression of its target gene Tfdp2 was increased after METH exposure. Overexpression of miR_146 or silencing of Tfdp2 significantly alleviated METH-induced cell cycle arrest and apoptosis in primary tree shrew neurons. These findings provide new insights into the role of the miR_146-Tfdp2 axis in METH-induced neurotoxic injury and offer a theoretical basis for miR_146 as potential therapeutic targets in drug abuse. - Source: PubMed
Publication date: 2025/01/09
Zhang ShuweiWang ChanLiu JianxingLiu LiuMiao LinWang HaoweiTian YunqingCheng HaoLi JuanZeng Xiaofeng - Triple-negative breast cancer (TNBC) is an aggressive molecular subtype of breast cancer characterized by a high recurrence rate, poor prognosis, and elevated mortality. Identifying novel molecular targets is crucial for developing more effective therapeutic strategies against TNBC. Recent studies have highlighted the role of circular RNAs (circRNAs) in the progression of TNBC. In this study, we identified and validated that circDUSP16 (hsa_circ_0003855) is significantly upregulated in TNBC cells, tissues, and plasma exosomes. Functional assays in vitro demonstrated that overexpression of circDUSP16 promoted the proliferation, migration and invasion of TNBC cells, weathers circDUSP16 knockdown exerted the opposite effect. In vivo studies confirmed that circDUSP16 knockdown can inhibit tumor growth. Using bioinformatics analysis, circDUSP16/miR-1224-3p/TFDP2 pathway was predicted and cascaded. Mechanistically, circDUSP16 was shown to promote the progression of TNBC via the miR-1224-3p/TFDP2 axis. Additionally, THP, a commonly used anthracycline chemotherapy drug, was found to downregulate circDUSP16, suggesting that its therapeutic effects on TNBC may be mediated through circDUSP16/miR-1224-3p/TFDP2 pathway. Our findings suggest that circDUSP16 is a promising biomarker and potential therapeutic target for TNBC. - Source: PubMed
Publication date: 2024/12/20
Wei DexianZhang FanLi MinFan ZhiminMa JiulongJi JiahuaQiao SennanHuang PengZhang WenqingFan KaiqiLi LuZheng WentaoLi XiangjunRen Liqun